N@N

Market Maker Surveillance Report. ONXX, PZZI, FSS, EGLE, CHTP, BMTI, Winning Stocks With Lowest Price Friction For Thursday, J

June 21, 2012 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Thursday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Thursday there were 3388 companies with "abnormal" market making, 1362 companies with positive Friction Factors and 4595 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Thursday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. ONYX PHARMACEUTICALS, INC. (NASDAQ:ONXX), Pizza Inn Inc (NASDAQ:PZZI), FEDERAL SIGNAL CORP (NYSE:FSS), EAGLE BULK SHIPPING INC (NASDAQ:EGLE), CHELSEA THERAPEUTICS INTERNATIONAL, LTD. (NASDAQ:CHTP), BIOMIMETIC THERAPEUTICS INC (NASDAQ:BMTI). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

  Symbol  Change    Percent   Buy Volume   Buy %%    Sell Volume  Sell %%   Net Volume   Friction
  ONXX    $19.270   43.23%    11,011,695   48.60%    9,737,367    42.98%    1,274,328    661     
  PZZI    $0.510    20.00%    88,841       57.74%    64,229       41.74%    24,612       483     
  FSS     $0.890    18.78%    352,481      27.36%    311,743      24.20%    40,738       458     
  EGLE    $0.930    31.21%    731,418      52.86%    640,122      46.26%    91,296       982     
  CHTP    $0.230    17.56%    2,682,570    50.22%    2,648,276    49.58%    34,294       1,491   
  BMTI    $0.450    16.67%    501,425      54.78%    406,974      44.46%    94,451       2,099   

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net buy volumes (buy volume, sell volume) and low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows ONXX with a dollar gain Thursday of $19.27000 and a Friction Factor of 661 shares. That means that it only took 661 more shares of buying than selling to move ONXX higher by one penny. The Market Makers are currently allowing the stock to rise quickly (low friction). The combination of low friction and positive market direction can drive prices higher much faster than normal.

ONYX PHARMACEUTICALS, INC. (NASDAQ:ONXX) - Onyx Pharmaceuticals, Inc., a biopharmaceutical company, engages in developing therapies targeting the molecular mechanisms causing cancer in the United States and internationally. Its lead product includes Nexavar (sorafenib) tablets, a novel, oral multiple kinase inhibitor that targets proteins involved in tumor cell proliferation and angiogenesis. This product is being developed and marketed in collaboration with Bayer HealthCare Pharmaceuticals. Its developing products include Nexavar for the treatment of liver cancer, kidney cancer, non-small cell lung cancer, thyroid cancer, breast cancer, ovarian cancer, and colorectal cancer; and Carfilzomib for the treatment of multiple myeloma and solid tumor. The company also develops ONX 0801, a Phase 1 clinical stage product, under a development and license agreement with BTG International Limited; and ONX 0912, an oral proteasome inhibitor. In addition, it develops ONX 0914, a preclinical stage product for the treatment of autoimmune disorders, such as rheumatoid arthritis, inflammatory bowel disease, and lupus. In addition, Onyx Pharmaceuticals, through a development collaboration, option, and license agreement with S*BIO Pte Ltd, owns options to license the rights of ONX 0803 and ONX 0805. ONX 0803 is an orally available, potent, and selective inhibitor of JAK2; and ONX 0805 is a JAK2 inhibitor. Further, the company has a research and development collaboration agreement with Warner-Lambert Company to discover and commercialize small molecule drugs that restore the control of, or otherwise intervene in, the misregulated cell cycle in tumor cells. Onyx Pharmaceuticals, Inc. was founded in 1992 and is headquartered in Emeryville, California.

Pizza Inn Inc (NASDAQ:PZZI) - Pizza Inn, Inc., together with its subsidiaries, operates and franchises pizza buffet, delivery/carry-out and express restaurants in the United States and internationally. Its buffet restaurants offer dine-in, carryout, and catering services, as well as delivery services. The companys delivery/carryout restaurants provide delivery and carryout services and are located in shopping centers or other in-line retail developments. Its express restaurants serve its customers through various non-traditional points of sale and are located in convenience stores, food courts, college campuses, airport terminals, athletic facilities, or other commercial facilities. The company operates restaurants under Pizza Inn trademark. As of June 27, 2010, it operated 312 restaurants, including 3 company-owned restaurants and 309 franchised restaurants. Pizza Inn, Inc. was founded in 1958 and is based in The Colony, Texas.

FEDERAL SIGNAL CORP (NYSE:FSS) - Federal Signal Corporation designs and manufactures a suite of products and integrated solutions for municipal, governmental, industrial, and commercial customers worldwide. The company operates in three segments: Safety and Security Systems, Fire Rescue, and Environmental Solutions. The Safety and Security Systems segment offers various systems for automated license plate recognition, campus and community alerting, emergency vehicles, first responder interoperable communications, industrial communications and command, municipal networked security, vehicle classification, parking revenue, and access control. This segment also provides products, such as lightbars and sirens, public warning sirens, and public safety software. The Fire Rescue segment offers articulated and telescopic aerial platforms for rescue, fire fighting, and maintenance purposes. This segment sells its products to municipal and industrial fire services, civil defense authorities, rental companies, electric utilities and industrial customers. The Environmental Solutions segment provides various self-propelled street cleaning vehicles, vacuum loader vehicles, municipal catch basin/sewer cleaning vacuum trucks, and water blasting equipment. The company was founded in 1901 and is based in Oak Brook, Illinois.

EAGLE BULK SHIPPING INC (NASDAQ:EGLE) - Eagle Bulk Shipping Inc. engages in the ocean transportation of bulk cargoes in the dry bulk industry. The company primarily transports iron ore, coal, grain, cement, and fertilizer along worldwide shipping routes. As of December 31, 2009, it owned and operated a fleet of 27 oceangoing vessels with a combined carrying capacity of 1,412,535 deadweight tons. The company was founded in 2005 and is headquartered in New York, New York.

CHELSEA THERAPEUTICS INTERNATIONAL, LTD. (NASDAQ:CHTP) - Chelsea Therapeutics International, Ltd., a development stage pharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of various human diseases. The companys compounds target various prevalent medical conditions, primarily rheumatoid arthritis, psoriasis, cancer, other immunological disorders, and neurogenic orthostatic hypotension associated with Parkinsons disease and other autonomic disorders. It offers Droxidopa, an orally active synthetic precursor of norepinephrine for the treatment of symptomatic neurogenic orthostatic hypotension, freezing gait in Parkinsons disease, and intradialytic hypotension in Japan. The company develops droxidopa in three indications, such as neurogenic orthostatic hypotension, intradialytic hypotension, and fibromyalgia. It also develops a portfolio of molecules for the treatment of various autoimmune/inflammatory diseases, such as a portfolio of metabolically inert antifolate molecules, including CH-1504 for the treatment of rheumatoid arthritis that is in a phase II head-to-head clinical trial; and CH-4051, which completed the phase I study designed to determine the maximum tolerated dose based on results of single-ascending and multiple-ascending dose evaluations. In addition, the company develops antifolate program, a platform consisting of a portfolio of dihydroorotate dehydrogenase(DHODH), inhibiting compounds known as the I-3D portfolio, a group of orally active compounds that inhibit the enzyme DHODH for the treatment of autoimmune diseases and transplant rejection. Chelsea Therapeutics International, Ltd. was founded in 2002 and is headquartered in Charlotte, North Carolina.

BIOMIMETIC THERAPEUTICS INC (NASDAQ:BMTI) - BioMimetic Therapeutics, Inc., a biotechnology company, engages in the development and commercialization of regenerative protein therapeutic-device combination products for the treatment of musculoskeletal injuries and conditions affecting bones, tendons, ligaments, and cartilage. The companys orthopedic products include Augment Bone Graft for open fracture and fusion treatment; and Augment Injectable Bone Graft for closed fracture treatment and minimally invasive fracture/fusion treatment. Its products also comprise Augment C to treat cartilage repair; Augment RC for rotator cuff tendon to bone repair; Augment AT for the treatment of acute tendon injuries; and Augment CT for chronic tendon injuries, as well as TBD, which is under development for spine fusion. The company was formerly known as BioMimetic Pharmaceuticals, Inc. and changed its name to BioMimetic Therapeutics, Inc. in July 2005. BioMimetic Therapeutics, Inc. was founded in 1999 and is headquartered in Franklin, Tennessee.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net